Special Session

Anticancer Drug Discovery from Mother Nature

Session Chairman

Anupam Bishayee, Ph.D
Larkin Health Sciences Institute



Steve Melnick, Ph.D, Nicklaus children`s hospital, USA
Title: Paradigm for Natural Product-Based Medicinal Discovery and Recent Innovations
Appu Rathinavelu Ph.D, Nova Southeastern University, USA
Title: Novel VEGFR2 Inhibitors for Treating Solid Tumors and Brain Metastasis
Ratna Ray Ph.D, Saint Louis University, USA
Title: Bitter Melon’s Sweet Promise: Role in Head and neck cancer
Kensese S. Mossanda Ph.D, Walter Sisulu University, South Africa
Title: Importance of the integration of African Traditional Medicine into the existing Health care system for Inflammatory diseases and Cancer
Hasan Mukhtar Ph.D, University of Wisconsin, USA
Title: Anti-cancer Activity of Fisetin, a Flavonoid from Mother Nature
Indraneel Mittra Ph.D, Tata Memorial Centre, India
Title: Resveratrol-copper: a novel extracellular DNA-degrading agent in the treatment of cancer
Archana R Juvekar Ph.D, Institute of Chemical Technology, India
Title: Bioactives from Cinnamomum tamala with Potential Antitumor Role
Dona Sinha Ph.D, Chittaranjan National Cancer Institure, India
Title: Tea Polyphenols as Modulators of Nrf2: Implication in Chemoprevention and Chemotherapeutics
Rahul R. Deshmukh Ph.D, LECOM School of Pharmacy, USA
Title: Targeting Ubiquitin Proteasome System with Natural Compounds: Implications in Anti-cancer Therapy
Deepak Bhatia, Ph.D, Shenandoah University, VA, USA
Title: Resveratrol driven suicide gene therapy for Non small cell carcinoma